logo-horizontal-main.png
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings
09 déc. 2024 16h05 HE | OncoCyte Corporation
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings – January 13-16, 2025, San Francisco, CA
logo-horizontal-main.png
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
04 déc. 2024 16h15 HE | OncoCyte Corporation
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
logo-horizontal-main.png
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
12 nov. 2024 16h05 HE | OncoCyte Corporation
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
logo-horizontal-main.png
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
06 nov. 2024 16h45 HE | OncoCyte Corporation
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
logo-horizontal-main.png
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
16 oct. 2024 16h15 HE | OncoCyte Corporation
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
logo-horizontal-main.png
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
12 août 2024 16h10 HE | OncoCyte Corporation
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Beta Costumer Revenue Path
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
08 août 2024 16h05 HE | OncoCyte Corporation
Oncocyte Announces Successful GraftAssureTM Beta Launch and Q2 2024 Results
logo-horizontal-main.png
Oncocyte Announces August Investor Conferences Participation
05 août 2024 16h05 HE | OncoCyte Corporation
Oncocyte Announces August Investor Conferences Participation
logo-horizontal-main.png
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
01 août 2024 16h05 HE | OncoCyte Corporation
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
MedTechGurus-Logo.jpg
MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode
11 juil. 2024 08h00 HE | Med Tech Gurus
MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode